Avalo Therapeutics, Inc. (AVTX): 424B5 filed Nov 5, 2026

Form type
424B5
Filing date
Nov 5, 2026
Accession number
0001104659-26-123069
Filer
Avalo Therapeutics, Inc. (CIK 1534120)